Concentra Group Holdings Parent, Inc. (CON) - Stock Analysis
Last updated: Sep 13, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Liquidity Improvement ⢠High Leverage CON's profitability, cash flow, and liquidity improved, but high leverage, intangible-asset exposure, and elevated valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Recent rebound ⢠Key resistance ⢠Support watch Support Level: $33.74â$33.88 Resistance Level: $35.00 and $35.37â$35.47 CON is cautiously constructive after rebounding from $33.74 and moving above its last-month average, but confirmation requires a sustained break above $35.47; otherwise, a drop below $33.74 would revive downside risk.
Sentiment & News
Key News Insights: ⢠Minnesota expansion ⢠Leadership transition ⢠Analyst upgrades Concentra's expansion, leadership upgrades, and favorable analyst attention strengthen its growth outlook and momentum appeal.
AI Summary
CON's thesis has shifted to proving that its margin and free-cash-flow acceleration can sustainably outpace leverage as expansion and leadership transitions raise execution risk; with valuation already elevated, investors should favor evidence of durable EBITDA growth and deleveraging over further acquisition-led growth.
Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational and consumer health services, operating clinic networks and onsite programs that deliver workersâ compensation care, urgent care, preventive and clinical testing, and employer health services. The company also offers telemedicine for work-related conditions, pharmacy services, and third-party administration for medical compliance and drug testing. Founded in 1979 and headquartered in Mechanicsburg, Pennsylvania, Concentra is a subsidiary of Select Medical Corporation.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Aug 26 | Sep 2 | CON | Concentra Group Holdings Parent, Inc. | Q2 revenue rose 10%, net income 46.5%, and adjusted EBITDA 22.5%; EPS beat consensus, full-year guidance was raised, and the stock gained 11.8% over 21 sessions with a rising moving average. | Closed | -2.6% |